146 related articles for article (PubMed ID: 9929507)
1. High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement.
Svensson US; Sandström R; Carlborg O; Lennernäs H; Ashton M
Drug Metab Dispos; 1999 Feb; 27(2):227-32. PubMed ID: 9929507
[TBL] [Abstract][Full Text] [Related]
2. The absence of stereoselective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum.
Sandström R; Karlsson A; Lennernäs H
J Pharm Pharmacol; 1998 Jul; 50(7):729-35. PubMed ID: 9720621
[TBL] [Abstract][Full Text] [Related]
3. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats.
Sandström R; Lennernäs H
Drug Metab Dispos; 1999 Aug; 27(8):951-5. PubMed ID: 10421625
[TBL] [Abstract][Full Text] [Related]
4. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
5. The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans.
Sandström R; Knutson TW; Knutson L; Jansson B; Lennernäs H
Br J Clin Pharmacol; 1999 Aug; 48(2):180-9. PubMed ID: 10417494
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with potent P-glycoprotein ligands may increase intestinal secretion in rats.
Hanafy A; Langguth P; Spahn-Langguth H
Eur J Pharm Sci; 2001 Feb; 12(4):405-15. PubMed ID: 11231107
[TBL] [Abstract][Full Text] [Related]
7. Comparison of intestinal permeability and p-glycoprotein effects on the intestinal absorption of enantiomers of 2-(2-hydroxypropanamido) benzoic acid in rats.
Zhang Q; Zhang M; Wang D; Zhao Y; Yu Z
Chirality; 2017 Jan; 29(1):26-32. PubMed ID: 27992072
[TBL] [Abstract][Full Text] [Related]
8. In Situ intestinal perfusion of irinotecan: application to P-gp mediated drug interaction and introduction of an improved HPLC assay.
Rabba AK; Si L; Xue K; Li M; Li G
J Pharm Pharm Sci; 2011; 14(2):138-47. PubMed ID: 21733405
[TBL] [Abstract][Full Text] [Related]
9. The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in rats.
Sababi M; Borgå O; Hultkvist-Bengtsson U
Eur J Pharm Sci; 2001 Aug; 14(1):21-7. PubMed ID: 11457646
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine.
Saitoh H; Aungst BJ
Pharm Res; 1995 Sep; 12(9):1304-10. PubMed ID: 8570526
[TBL] [Abstract][Full Text] [Related]
11. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
12. Intestinal permeability of metformin using single-pass intestinal perfusion in rats.
Song NN; Li QS; Liu CX
World J Gastroenterol; 2006 Jul; 12(25):4064-70. PubMed ID: 16810761
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus is a class II low-solubility high-permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats.
Tamura S; Ohike A; Ibuki R; Amidon GL; Yamashita S
J Pharm Sci; 2002 Mar; 91(3):719-29. PubMed ID: 11920757
[TBL] [Abstract][Full Text] [Related]
14. Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.
Chiu YY; Higaki K; Neudeck BL; Barnett JL; Welage LS; Amidon GL
Pharm Res; 2003 May; 20(5):749-56. PubMed ID: 12751630
[TBL] [Abstract][Full Text] [Related]
15. Jejunal absorption and metabolism of R/S-verapamil in humans.
Sandström R; Karlsson A; Knutson L; Lennernäs H
Pharm Res; 1998 Jun; 15(6):856-62. PubMed ID: 9647350
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil.
Shen JY; Yang XL; Yang ZL; Kou JP; Li F
Drug Des Devel Ther; 2015; 9():4685-93. PubMed ID: 26316707
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
18. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
Incecayir T; Tsume Y; Amidon GL
Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeability of forskolin by in situ single pass perfusion in rats.
Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY
Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
